Our data collectively indicate that BMP9‐ID1 signaling regulates the expression of EpCAM through the activation of Wnt/β‐catenin signaling, resulting in the promotion of EpCAM+ HCC‐CSC properties. Here, GDF2 is linked to hepatocellular carcinoma.